Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE

The First Affiliated Hospital with Nanjing Medical University · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
cholangiocarcinoma
cholangiocarcinoma cancer, adebrelimab (shr-1316), adebrelimab, capecitabine, cholangiocarcinoma, adjuvant therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 901780
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.